319 related articles for article (PubMed ID: 32692719)
21. Overexpression of peroxiredoxin 2 inhibits TGF-β1-induced epithelial-mesenchymal transition and cell migration in colorectal cancer.
Feng J; Fu Z; Guo J; Lu W; Wen K; Chen W; Wang H; Wei J; Zhang S
Mol Med Rep; 2014 Aug; 10(2):867-73. PubMed ID: 24920174
[TBL] [Abstract][Full Text] [Related]
22. LINC02595 promotes tumor progression in colorectal cancer by inhibiting miR-203b-3p activity and facilitating BCL2L1 expression.
Yang Z; An Y; Wang N; Dong X; Kang H
J Cell Physiol; 2020 Oct; 235(10):7449-7464. PubMed ID: 32064615
[TBL] [Abstract][Full Text] [Related]
23. P38 MAP kinase functions as a switch in MS-275-induced reactive oxygen species-dependent autophagy and apoptosis in human colon cancer cells.
Zhan Y; Gong K; Chen C; Wang H; Li W
Free Radic Biol Med; 2012 Aug; 53(3):532-43. PubMed ID: 22634147
[TBL] [Abstract][Full Text] [Related]
24. Osteopontin Promotes Cell Migration and Invasion, and Inhibits Apoptosis and Autophagy in Colorectal Cancer by activating the p38 MAPK Signaling Pathway.
Huang RH; Quan YJ; Chen JH; Wang TF; Xu M; Ye M; Yuan H; Zhang CJ; Liu XJ; Min ZJ
Cell Physiol Biochem; 2017; 41(5):1851-1864. PubMed ID: 28376477
[TBL] [Abstract][Full Text] [Related]
25. Redox-sensitive cyclophilin A elicits chemoresistance through realigning cellular oxidative status in colorectal cancer.
Peng L; Jiang J; Chen HN; Zhou L; Huang Z; Qin S; Jin P; Luo M; Li B; Shi J; Xie N; Deng LW; Liou YC; Nice EC; Huang C; Wei Y
Cell Rep; 2021 Nov; 37(9):110069. PubMed ID: 34852234
[TBL] [Abstract][Full Text] [Related]
26. FOXC2 promotes colorectal cancer proliferation through inhibition of FOXO3a and activation of MAPK and AKT signaling pathways.
Cui YM; Jiang D; Zhang SH; Wu P; Ye YP; Chen CM; Tang N; Liang L; Li TT; Qi L; Wang SY; Jiao HL; Lin J; Ding YQ; Liao WT
Cancer Lett; 2014 Oct; 353(1):87-94. PubMed ID: 25069037
[TBL] [Abstract][Full Text] [Related]
27.
Long ZH; Bai ZG; Song JN; Zheng Z; Li J; Zhang J; Cai J; Yao HW; Wang J; Yang YC; Yin J; Zhang ZT
Anticancer Res; 2017 Aug; 37(8):4345-4352. PubMed ID: 28739727
[TBL] [Abstract][Full Text] [Related]
28. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
Wang J; Zhao X; Jin L; Wu G; Yang Y
Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
[TBL] [Abstract][Full Text] [Related]
29. p38-regulated FOXC1 stability is required for colorectal cancer metastasis.
Zhang Y; Liao Y; Chen C; Sun W; Sun X; Liu Y; Xu E; Lai M; Zhang H
J Pathol; 2020 Feb; 250(2):217-230. PubMed ID: 31650548
[TBL] [Abstract][Full Text] [Related]
30. RNF216 contributes to proliferation and migration of colorectal cancer via suppressing BECN1-dependent autophagy.
Wang H; Wang Y; Qian L; Wang X; Gu H; Dong X; Huang S; Jin M; Ge H; Xu C; Zhang Y
Oncotarget; 2016 Aug; 7(32):51174-51183. PubMed ID: 27203674
[TBL] [Abstract][Full Text] [Related]
31. Prdx2 Upregulation Promotes the Growth and Survival of Gastric Cancer Cells.
Zhang S; He J; Tang M; Sun H
Pathol Oncol Res; 2020 Jul; 26(3):1869-1877. PubMed ID: 31807984
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of RPL9 expression inhibits colorectal carcinoma growth via the inactivation of Id-1/NF-κB signaling axis.
Baik IH; Jo GH; Seo D; Ko MJ; Cho CH; Lee MG; Lee YH
Int J Oncol; 2016 Nov; 49(5):1953-1962. PubMed ID: 27633352
[TBL] [Abstract][Full Text] [Related]
33. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
[TBL] [Abstract][Full Text] [Related]
34. S100A6 stimulates proliferation and migration of colorectal carcinoma cells through activation of the MAPK pathways.
Duan L; Wu R; Zou Z; Wang H; Ye L; Li H; Yuan S; Li X; Zha H; Sun H; Zhang Y; Chen X; Zhou L
Int J Oncol; 2014 Mar; 44(3):781-90. PubMed ID: 24378749
[TBL] [Abstract][Full Text] [Related]
35. PRDX2 protects against oxidative stress induced by H. pylori and promotes resistance to cisplatin in gastric cancer.
Wang S; Chen Z; Zhu S; Lu H; Peng D; Soutto M; Naz H; Peek R; Xu H; Zaika A; Xu Z; El-Rifai W
Redox Biol; 2020 Jan; 28():101319. PubMed ID: 31536951
[TBL] [Abstract][Full Text] [Related]
36. MKK3 sustains cell proliferation and survival through p38DELTA MAPK activation in colorectal cancer.
Stramucci L; Pranteda A; Stravato A; Amoreo CA; Pennetti A; Diodoro MG; Bartolazzi A; Milella M; Bossi G
Cell Death Dis; 2019 Nov; 10(11):842. PubMed ID: 31695024
[TBL] [Abstract][Full Text] [Related]
37. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
[TBL] [Abstract][Full Text] [Related]
38. Silencing of FOXO6 inhibits the proliferation, invasion, and glycolysis in colorectal cancer cells.
Li Q; Tang H; Hu F; Qin C
J Cell Biochem; 2019 Mar; 120(3):3853-3860. PubMed ID: 30321450
[TBL] [Abstract][Full Text] [Related]
39. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
[TBL] [Abstract][Full Text] [Related]
40. Combination of targeting CD24 and inhibiting autophagy suppresses the proliferation and enhances the apoptosis of colorectal cancer cells.
Zhuo J; Wang X
Mol Med Rep; 2019 Jul; 20(1):539-548. PubMed ID: 31180548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
